Optometrists in Phoenixville, PA Accepting Medicare

27 Optometrists found. Showing 21 - 27

Kaylee M Ho, OD Optometrist Medicare: Medicare Enrolled Practice Location: 501 Kimberton Rd, Phoenixville, PA 19460 Phone: 610-917-9999

Barry R Fabriziani, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 286 Griffen St, Phoenixville, PA 19460 Phone: 610-933-1144    Fax: 610-933-7067

Kayla Marie Bond, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 720 Main St, Phoenixville, PA 19460 Phone: 610-933-3498    Fax: 610-933-5052

Thomas M Gulibon Jr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 720 Main St, Phoenixville, PA 19460 Phone: 610-933-3498    Fax: 610-933-5052

Mr. Ryan Naglak, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 720 Main St, Phoenixville, PA 19460 Phone: 610-933-3498    Fax: 610-933-5052

Robert S Susan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 523 Kimberton Rd, Suite 11c, Phoenixville, PA 19460 Phone: 610-933-2177    Fax: 610-933-8782

Dr. Robert A Peifer Jr., O.D. Optometrist - Corneal and Contact Management Medicare: Not Enrolled in Medicare Practice Location: 283 Schuylkill Rd, Phoenixville, PA 19460 Phone: 610-933-6676    Fax: 610-933-6679

News Archive

Time, therapy spur recovery from sudden sensorineural hearing loss

A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.

Machine learning can predict emerging infectious diseases

Machine learning can pinpoint rodent species that harbor diseases and geographic hotspots vulnerable to new parasites and pathogens. So reports a new study in the Proceedings of the National Academy of Sciences led by Barbara A. Han, a disease ecologist at the Cary Institute of Ecosystem Studies.

Cancer drug nilotinib found to be safe and well-tolerated in Alzheimer's disease clinical trial

A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.

COMP issues positive opinion for Æterna Zentaris' perifosine orphan medicinal product designation

Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)